Bausch Health

RETISERT

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Bausch Health

Retisert HCPCS:

J7311

HCPCS Code Descriptor:

Injection, fluocinolone acetonide, intravitreal implant (retisert), 0.01 mg

Category:

J Code

Retisert NDCs:

24208-0416-01

Primary Type:

Opthalmic

Generic/Specialty Status:

Single-Source

Package Type:

Packet

Route of Administration:

Intraocular

Retisert CPT Codes:

-67027 - Implantation of intravitreal drug delivery system (eg, ganciclovir implant), includes concomitant removal of vitreous

-99211-99215 - Evaluation and Management (E/M) Services

Some of the most common CPT administration codes for 'buy and bill' drugs can be found at the following link:

Potential NDC Listing Errors:

We have not identified any potential errors with the NDCs mapped to this HCPCS code.

About Retisert:

RETISERT is an Opthalmic drug manufactured by Bausch Health and administered via the Intraocular route of administration. The J Code: J7311 is aligned to the drug RETISERT.

ACCESS PRICING AND MORE BY REGISTERING

J7311 Added Date:

January 1, 2007

J7311 Effective Date:

October 1, 2019

J7311 Termination Date:

HCPCS Active

Retisert billing and coding information can be found through Bausch Health at the link below:
Retisert patient assistance information can be found through The Focus On Access Program at the URL: https://www.bauschretinarx.com/focusonaccess/
RETISERT prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for RETISERT. Please check back in a few weeks.